| Dr Zaid Sameer Aljuboori, MD, | |
|
1000 E Mountain Dr, Wilkes Barre, PA 18711-0027 | |
| (570) 808-3290 | |
| (570) 808-3298 |
| Full Name | Dr Zaid Sameer Aljuboori |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 16 Years |
| Location | 1000 E Mountain Dr, Wilkes Barre, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518233410 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Geisinger Wyoming Valley Medical Center | Wilkes barre, PA | Hospital |
| Geisinger-community Medical Center | Scranton, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Geisinger Clinic | 5395657001 | 2866 |
News Archive
Results of a randomised trial in this week's issue of THE LANCET highlight how the low-cost antibiotic co-trimoxazole should be given to all children with HIV in developing countries to help reduce illness and death from opportunistic infections such as pneumonia.
Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced U.S. Food and Drug Administration approval of its most advanced transcatheter aortic heart valve – the Edwards SAPIEN 3 valve with the Commander Delivery System – for the treatment of high-risk patients suffering from severe, symptomatic aortic stenosis.
Researchers from the University of Barcelona have described an interaction between the protein HNRNPA2B1 and pancreatic cancer development which remained unknown. The study, published in the journal Gastroenterology, has proved in human cancer cell lines that this protein is essential to the correct activity of the oncogenic protein KRAS, related to cancer start and development.
A 'magic bullet' designed by pharmaceutical scientists at an English university could eradicate the side effects of a drug used to treat a rare genetic disease. Researchers at the University of Sunderland have chemically modified a drug used to treat cystinosis a disease which occurs when the body's mechanism to remove excess cystine (an amino acid) breaks down, leading to kidney problems and eventually affecting other organs to remove unpleasant side effects such as nausea, vomiting, severe halitosis, body odour and a noxious taste.
Elderly carers have larger social networks and are not as lonely as other people in their age group, according to a paper in the Journal of Advanced Nursing. They also tend to be healthier and have a better quality of life.
› Verified 9 days ago
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
Results of a randomised trial in this week's issue of THE LANCET highlight how the low-cost antibiotic co-trimoxazole should be given to all children with HIV in developing countries to help reduce illness and death from opportunistic infections such as pneumonia.
Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced U.S. Food and Drug Administration approval of its most advanced transcatheter aortic heart valve – the Edwards SAPIEN 3 valve with the Commander Delivery System – for the treatment of high-risk patients suffering from severe, symptomatic aortic stenosis.
Researchers from the University of Barcelona have described an interaction between the protein HNRNPA2B1 and pancreatic cancer development which remained unknown. The study, published in the journal Gastroenterology, has proved in human cancer cell lines that this protein is essential to the correct activity of the oncogenic protein KRAS, related to cancer start and development.
A 'magic bullet' designed by pharmaceutical scientists at an English university could eradicate the side effects of a drug used to treat a rare genetic disease. Researchers at the University of Sunderland have chemically modified a drug used to treat cystinosis a disease which occurs when the body's mechanism to remove excess cystine (an amino acid) breaks down, leading to kidney problems and eventually affecting other organs to remove unpleasant side effects such as nausea, vomiting, severe halitosis, body odour and a noxious taste.
Elderly carers have larger social networks and are not as lonely as other people in their age group, according to a paper in the Journal of Advanced Nursing. They also tend to be healthier and have a better quality of life.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Zaid Sameer Aljuboori, MD, 100 N Academy Ave, Danville, PA 17822-4903 Ph: (570) 271-6144 | Dr Zaid Sameer Aljuboori, MD, 1000 E Mountain Dr, Wilkes Barre, PA 18711-0027 Ph: (570) 808-3290 |
News Archive
Results of a randomised trial in this week's issue of THE LANCET highlight how the low-cost antibiotic co-trimoxazole should be given to all children with HIV in developing countries to help reduce illness and death from opportunistic infections such as pneumonia.
Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced U.S. Food and Drug Administration approval of its most advanced transcatheter aortic heart valve – the Edwards SAPIEN 3 valve with the Commander Delivery System – for the treatment of high-risk patients suffering from severe, symptomatic aortic stenosis.
Researchers from the University of Barcelona have described an interaction between the protein HNRNPA2B1 and pancreatic cancer development which remained unknown. The study, published in the journal Gastroenterology, has proved in human cancer cell lines that this protein is essential to the correct activity of the oncogenic protein KRAS, related to cancer start and development.
A 'magic bullet' designed by pharmaceutical scientists at an English university could eradicate the side effects of a drug used to treat a rare genetic disease. Researchers at the University of Sunderland have chemically modified a drug used to treat cystinosis a disease which occurs when the body's mechanism to remove excess cystine (an amino acid) breaks down, leading to kidney problems and eventually affecting other organs to remove unpleasant side effects such as nausea, vomiting, severe halitosis, body odour and a noxious taste.
Elderly carers have larger social networks and are not as lonely as other people in their age group, according to a paper in the Journal of Advanced Nursing. They also tend to be healthier and have a better quality of life.
› Verified 9 days ago
Dr. Victor Chukwuemeka Udekwu, M.D Neurological Surgery Medicare: May Accept Medicare Assignments Practice Location: 545 N River St Ste 240, Wilkes Barre, PA 18702 Phone: 570-706-2620 Fax: 570-706-2627 | |
Jeffrey Daniel Oliver, Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1000 E Mountain Dr, Wilkes Barre, PA 18711 Phone: 570-808-3290 Fax: 570-808-3298 | |
Dr. John H. Presper, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-819-5370 Fax: 570-819-5371 | |
Kenneth C Liu, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-808-6026 Fax: 570-808-3298 | |
Dr. Michel Lacroix, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-820-6026 Fax: 570-826-7943 | |
Itay Melamed, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-808-6026 Fax: 570-808-3298 |